Press communication 12.18.2018

The main scientific results and methods developed within the CiPA3 project were included in a patent application submitted to the European Patenting Office on October 24, 2018 (application number EP18465611.4). The application contains a detailed description of the experimental and modeling methods combined in a new type of cardiac safety in vitro pharmacology assay, consisting […]

Press communication 12.11.2018

The scientific results of the CiPA3 projects were presented at the Safety Pharmacology Society 2018 Annual Meeting in Washington, DC (September 30 – October 3, 2018) within a poster entitled “Development of a New CiPA-compliant MOA in vitro Assay on Stem Cell-Derived Cardiomyocytes including Automated Data Analysis and Model Parameter Optimization”, authors: Stefan Mann, Juliane […]